Author:
Demma Shirin,Tsochatzis Emmanouil,Dusheiko Geoffrey
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–9.
2. Wallace MC, Preen D, Jeffrey GP, Adams LA. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev Gastroenterol Hepatol. 2015:1–15.
3. Sherman M, Kim RW, Dziura J. Risk scores for hepatocellular carcinoma in chronic hepatitis B. Hepatology (Baltimore, Md). 2015. Important analysis of risk scores in hepatocellular carcinoma.
4. WHO guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015. New WHO guidelines that determine management policy for policy makers worldwide, in order to reduce the morbidity from chronic hepatitis B.
5. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127(2):164–76.